Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-145-5 | CAS number: 2052-25-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Toxicokinetic assessment
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Introduction
Toxicokinetic parameters such as uptake, distribution, metabolism and excretion form the essential toxicological profile of a substance. An approximate indication of the toxicokinetic pattern can be gained from the physico-chemical properties taking into account the molecular weight, the number of atoms (hydrogen bond donors and acceptors), the solubility in solvents, log KOW, etc. and the results of basic toxicity testing of the test article. The assessment of the toxicokinetic properties of Mordant Black 9 given below is based on the results obtained for, the following toxicological endpoints:
· Acute oral toxicity in rats
· In vivo skin irritation in rabbits
· In vivo eye irritation in rabbits
· Bacterial reverse mutation test
Allstudieswere carried out according to the principles of Good Laboratory Practice and met the requirements of the OECD and EU-Guideline for the Testing of Chemicals.
Physico-chemical properties
Name: Mordant Black 9
CAS number: 2052-25-7,85750-02-3
CAS name: Benzenesulfonic acid, 3-((1,5-dihydroxy-2-naphthalenyl)azo)-4-hydroxy-, sodium salt
Empirical formula: C16H11N2NaO6S
Molecular weight: 382.3g/mol (<500 daltons = good absorption)
Atom count (natoms): 26 (<70 = good bioavailability)
H-bond acceptor (nON): 8 (<10 = good bioavailability)
H-bond donor (nOHNH): 3 (<5 = good bioavailability)
CAS number: 25747-07-3
CAS name: Benzenesulfonic acid, 3-((1,5-dihydroxy-2-naphthalenyl)azo)-4-hydroxy-
Empirical formula: C16H12N2O6S
Molecular weight: 360.3 g/mol (<500 daltons = good absorption)
Atom count (natoms): 25 (<70 = good bioavailability)
H-bond acceptor (nON): 8 (<10 = good bioavailability)
H-bond donor (nOHNH): 4 (<5 = good bioavailability)
Physical state: solid, black odourless powder
Water solubility: 48 g/L (= soluble in water)
Partition coefficient: log Kow= -1.4 (<-0.4 or >5.6 =bad absorption)
Surface tension: 48.2 mN/m (<60 = surface active)
Melting point: > 400°C (not volatile = not inhalable)
Vapor pressure: 3.31E-8 hPa (not volatile = not inhalable)
Toxicological Profile
After single oral administration of Mordant Black 9 at a dose level of 5000 mg/kg body weight to male and female rats no deaths or clinical signs other than unspecific signs of toxicity occurred. The median lethal dose (LD50) of Mordant Black 9 after oral administration to rats is greater than 5000 mg/kg body weight. Testing for skin irritating properties of Mordant Black 9 in rabbits did not lead to any adverse effects.
Mordant Black 9 was tested for bacterial mutagenicity in the presence and absence of rat and hamster S9-mix. The test compound did not cause a significant increase in the number of revertant colonies with any of the tester strains either in the absence or in the presence of S9-mix in either of these tests.
Evaluation and Assessment
Based on all available data, Mordant Black 9 does not exhibit a conspicuous toxicokinetic behavior.
Mordant Black 9 is a dark blue powdered solid at room temperature conditions. The degree of purity of the substance is 40 - 80%. The melting point of the substance is >400°C therefore a significant inhalation exposure to vapours is not expected. In view of the good water solubility and the low n-octanol/water partition coefficient (log Kow = – 1.4 at 20°C), systemic bioavailability after dermal exposure is not anticipated. This in accordance with the dermal irritation test.
Physico-chemical data such as molecular weight, atom count, number of H-bond donor and acceptors give evidence of a good oral systemic bioavailability. However, according to the data of the acute oral toxicity testing, Mordant Black 9 has a very low acute toxicity potential.
According to its molecular weight, Mordant Black 9 is most likely predominantly eliminated via intestine, as substances with a molecular weight above 300 g/mol are preferentially excreted via the feces in rats. However, it is most likely that the test compound is at least partly eliminated via kidneys/urine, too.
According to its low log Kow and the bioaccumulation modeling a significant bioaccumulation potential of Mordant Black 9 can be excluded.
Additionally, Mordant Black 9 was also not genotoxic in an in-vitro cell mutagenicity test. Therefore, a metabolisation towards genotoxic structures can most probably be excluded.
Summary
The results of basic toxicity testing give no reason to anticipate unusual characteristics with regards to the toxicokinetics of Mordant Black 9. The data indicate that there is little or no dermal absorption. No signs of a significant systemic toxicity associated with absorption potential have been observed. Bioaccumulation of Mordant Black 9 can most probably be excluded due to the available data. Based on the results of genotoxicity assays, a metabolisation towards genotoxic metabolites can also be excluded.
On the basis of the results, it is anticipated that the substance does not undergo significant metabolic activity; rather it is metabolized for excretion with little subsequent toxicity. The substance is therefore not considered to be of concern for ADME related effects.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.